A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Trial Profile

A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs Mecobalamin (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 29 Feb 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Mar 2016, according to ClinicalTrials.gov record.
    • 29 Feb 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.
    • 26 Dec 2014 Planned End Date changed from 1 Feb 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top